Locally advanced triple-negative breast cancer
Clinical trials for Locally advanced triple-negative breast cancer explained in plain language.
Never miss a new study
Get alerted when new Locally advanced triple-negative breast cancer trials appear
Sign up with your email to follow new studies for Locally advanced triple-negative breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink tough breast cancer tumors
Disease control Recruiting nowThis study tests whether adding a new drug called BEBT-209 to standard chemotherapy can shrink tumors and help people with advanced triple-negative breast cancer live longer. About 446 women aged 18 to 75 will be randomly assigned to receive either BEBT-209 plus two chemo drugs o…
Matched conditions: LOCALLY ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase 2/3 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Eczema drug shows promise in breast cancer trial
Disease control Recruiting nowThis early-phase trial is testing whether adding dupilumab (an eczema and asthma drug) to standard immunotherapy and chemotherapy can safely improve outcomes for people with locally advanced triple-negative breast cancer. About 15 participants will receive the combination before …
Matched conditions: LOCALLY ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Early phase 1 • Sponsor: Rima Patel • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC